Jing Yang

机构：Yinchuan First People's Hospital, Ningxia Medical University, Anhui Provincial Hospital · ORCID：0000-0003-1780-1659

发表论文 143 篇 · 总被引 14765 次 · h-index 37

代表论文

• Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer (2023 · New England Journal of Medicine · 被引 1096)
• Structural variants involved in high-altitude adaptation detected using single-molecule long-read sequencing (2023 · Nature Communications · 被引 34)
• Design, synthesis and evaluation of quinoline- O -carbamate derivatives as multifunctional agents for the treatment of Alzheimer’s disease (2023 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 31)
• KEYNOTE-671: Randomized, double-blind, phase 3 study of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early stage NSCLC. (2023 · Journal of Clinical Oncology · 被引 21)
• Pembrolizumab vs placebo for early-stage non‒small-cell lung cancer after resection and adjuvant therapy: Subgroup analysis of patients who received adjuvant chemotherapy in the phase 3 PEARLS/KEYNOTE-091 study. (2023 · Journal of Clinical Oncology · 被引 19)
• Sepsis: the evolution of molecular pathogenesis concepts and clinical management (2025 · MedComm · 被引 16)